For: | Onishi H, Katano M. Hedgehog signaling pathway as a new therapeutic target in pancreatic cancer. World J Gastroenterol 2014; 20(9): 2335-2342 [PMID: 24605030 DOI: 10.3748/wjg.v20.i9.2335] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v20/i9/2335.htm |
Number | Citing Articles |
1 |
Mian Wei, Rong Ma, Shaoliang Huang, Yan Liao, Youxiang Ding, Zhaohe Li, Qinglong Guo, Renxiang Tan, Lulu Zhang, Li Zhao. Oroxylin A increases the sensitivity of temozolomide on glioma cells by hypoxia‐inducible factor 1α/hedgehog pathway under hypoxia. Journal of Cellular Physiology 2019; 234(10): 17392 doi: 10.1002/jcp.28361
|
2 |
Jian Guo, Huating Zeng, Yan Chen. Emerging Nano Drug Delivery Systems Targeting Cancer-Associated Fibroblasts for Improved Antitumor Effect and Tumor Drug Penetration. Molecular Pharmaceutics 2020; 17(4): 1028 doi: 10.1021/acs.molpharmaceut.0c00014
|
3 |
Anmada Nayak, Shakti Ranjan Satapathy, Dipon Das, Sumit Siddharth, Neha Tripathi, Prasad V. Bharatam, ChanakyaNath Kundu. Nanoquinacrine induced apoptosis in cervical cancer stem cells through the inhibition of hedgehog-GLI1 cascade: Role of GLI-1. Scientific Reports 2016; 6(1) doi: 10.1038/srep20600
|
4 |
Jun Zou, Sha Yang, Chongwu He, Lei Deng, Bangran Xu, Shuai Chen. miR-630 as a therapeutic target in pancreatic cancer stem cells: modulation of the PRKCI-Hedgehog signaling axis. Biology Direct 2024; 19(1) doi: 10.1186/s13062-024-00539-1
|
5 |
D Amar, S Izraeli, R Shamir. Utilizing somatic mutation data from numerous studies for cancer research: proof of concept and applications. Oncogene 2017; 36(24): 3375 doi: 10.1038/onc.2016.489
|
6 |
Destina Ekingen Genc, Ozlem Ozbek, Burcu Oral, Ramazan Yıldırım, Nazar Ileri Ercan. Phytochemicals in Pancreatic Cancer Treatment: A Machine Learning Study. ACS Omega 2024; 9(1): 413 doi: 10.1021/acsomega.3c05861
|
7 |
Motahareh Mortazavi, Fatemeh Moosavi, Miriam Martini, Elisa Giovannetti, Omidreza Firuzi. Prospects of targeting PI3K/AKT/mTOR pathway in pancreatic cancer. Critical Reviews in Oncology/Hematology 2022; 176: 103749 doi: 10.1016/j.critrevonc.2022.103749
|
8 |
Jun Zhao, Huamin Wang, Cheng-Hui Hsiao, Diana S.-L. Chow, Eugene J. Koay, Yaan Kang, Xiaoxia Wen, Qian Huang, Ying Ma, James A. Bankson, Stephen E. Ullrich, Willem Overwijk, Anirban Maitra, David Piwnica-Worms, Jason B. Fleming, Chun Li. Simultaneous inhibition of hedgehog signaling and tumor proliferation remodels stroma and enhances pancreatic cancer therapy. Biomaterials 2018; 159: 215 doi: 10.1016/j.biomaterials.2018.01.014
|
9 |
Negin Rahnama, Mohammadsaleh Jahangir, Samira Alesaeid, Mohammad Saeed kahrizi, Ali Adili, Rebar N. Mohammed, Ramin Aslaminabad, Morteza Akbari, Ali Mert Özgönül. Association between microRNAs and chemoresistance in pancreatic cancer: Current knowledge, new insights, and forthcoming perspectives. Pathology - Research and Practice 2022; 236: 153982 doi: 10.1016/j.prp.2022.153982
|
10 |
Bolun Jiang, Li Zhou, Jun Lu, Yizhi Wang, Chengxi Liu, Lei You, Junchao Guo. Stroma-Targeting Therapy in Pancreatic Cancer: One Coin With Two Sides?. Frontiers in Oncology 2020; 10 doi: 10.3389/fonc.2020.576399
|
11 |
James A. McCubrey, Dariusz Rakus, Agnieszka Gizak, Linda S. Steelman, Steve L. Abrams, Kvin Lertpiriyapong, Timothy L. Fitzgerald, Li V. Yang, Giuseppe Montalto, Melchiorre Cervello, Massimo Libra, Ferdinando Nicoletti, Aurora Scalisi, Francesco Torino, Concettina Fenga, Luca M. Neri, Sandra Marmiroli, Lucio Cocco, Alberto M. Martelli. Effects of mutations in Wnt/β-catenin, hedgehog, Notch and PI3K pathways on GSK-3 activity—Diverse effects on cell growth, metabolism and cancer. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research 2016; 1863(12): 2942 doi: 10.1016/j.bbamcr.2016.09.004
|
12 |
Azam Rajabpour, Farzad Rajaei, Ladan Teimoori-Toolabi. Molecular alterations contributing to pancreatic cancer chemoresistance. Pancreatology 2017; 17(2): 310 doi: 10.1016/j.pan.2016.12.013
|
13 |
Chang Liu, Rensheng Wang. The Roles of Hedgehog Signaling Pathway in Radioresistance of Cervical Cancer. Dose-Response 2019; 17(4) doi: 10.1177/1559325819885293
|
14 |
Wei Li, Shuanlin Miao, Manyuan Miao, Renshuan Li, Xiaopeng Cao, Kun Zhang, Genzuan Huang, Bin Fu. Hedgehog Signaling Activation in Hepatic Stellate Cells Promotes Angiogenesis and Vascular Mimicry in Hepatocellular Carcinoma. Cancer Investigation 2016; 34(9): 424 doi: 10.1080/07357907.2016.1227442
|
15 |
Bo Ren, Ming Cui, Gang Yang, Huanyu Wang, Mengyu Feng, Lei You, Yupei Zhao. Tumor microenvironment participates in metastasis of pancreatic cancer. Molecular Cancer 2018; 17(1) doi: 10.1186/s12943-018-0858-1
|
16 |
Huifa Ma, Yongsheng Tian, Xiangyang Yu. Targeting Smoothened Sensitizes Gastric Cancer to Chemotherapy in Experimental Models. Medical Science Monitor 2017; 23: 1493 doi: 10.12659/MSM.903012
|
17 |
David Vetvicka, Ladislav Sivak, Chinmay M. Jogdeo, Raj Kumar, Rubayat Khan, Yu Hang, David Oupický. Gene silencing delivery systems for the treatment of pancreatic cancer: Where and what to target next?. Journal of Controlled Release 2021; 331: 246 doi: 10.1016/j.jconrel.2021.01.020
|
18 |
Chandrayee Ghosh, Santanu Paul, Prasad Dandawate, Sumedha S. Gunewardena, Dharmalingam Subramaniam, Cameron West, Shrikant Anant, Animesh Dhar. Super-enhancers: novel target for pancreatic ductal adenocarcinoma. Oncotarget 2019; 10(16): 1554 doi: 10.18632/oncotarget.26704
|
19 |
Agnieszka A. Rucki, Qian Xiao, Stephen Muth, Jianlin Chen, Xu Che, Jennifer Kleponis, Rajni Sharma, Robert A. Anders, Elizabeth M. Jaffee, Lei Zheng. Dual Inhibition of Hedgehog and c-Met Pathways for Pancreatic Cancer Treatment. Molecular Cancer Therapeutics 2017; 16(11): 2399 doi: 10.1158/1535-7163.MCT-16-0452
|
20 |
Sepideh Ardalan Khales, Mohammad Mahdi Forghanifard, Mohammad Reza Abbaszadegan, Seyed Ebrahim Hosseini. EZH2 deregulates BMP, Hedgehog, and Hippo cell signaling pathways in esophageal squamous cell carcinoma. Advances in Medical Sciences 2023; 68(1): 21 doi: 10.1016/j.advms.2022.11.002
|
21 |
Jungwhoi Lee, Jeong Hun Yun, Jungsul Lee, Chulhee Choi, Jae Hoon Kim. Blockade of dual-specificity phosphatase 28 decreases chemo-resistance and migration in human pancreatic cancer cells. Scientific Reports 2015; 5(1) doi: 10.1038/srep12296
|
22 |
LIANG CHANG, DAN ZHAO, HUI-BIN LIU, QIU-SHI WANG, PING ZHANG, CHEN-LONG LI, WEN-ZHONG DU, HONG-JUN WANG, XING LIU, ZHI-REN ZHANG, CHUAN-LU JIANG. Activation of sonic hedgehog signaling enhances cell migration and invasion by induction of matrix metalloproteinase-2 and -9 via the phosphoinositide-3 kinase/AKT signaling pathway in glioblastoma. Molecular Medicine Reports 2015; 12(5): 6702 doi: 10.3892/mmr.2015.4229
|
23 |
Michela Cortesi, Michele Zanoni, Francesca Pirini, Maria Maddalena Tumedei, Sara Ravaioli, Ilario Giovanni Rapposelli, Giovanni Luca Frassineti, Sara Bravaccini. Pancreatic Cancer and Cellular Senescence: Tumor Microenvironment under the Spotlight. International Journal of Molecular Sciences 2021; 23(1): 254 doi: 10.3390/ijms23010254
|
24 |
Sabrina Bimonte, Antonio Barbieri, Maddalena Leongito, Giuseppe Palma, Vitale del Vecchio, Michela Falco, Raffaele Palaia, Vittorio Albino, Mauro Piccirillo, Alfonso Amore, Antonella Petrillo, Vincenza Granata, Francesco Izzo, Hu Li. The Role of miRNAs in the Regulation of Pancreatic Cancer Stem Cells. Stem Cells International 2016; 2016(1) doi: 10.1155/2016/8352684
|
25 |
Ahmed H.E. Hassan, Cai Yi Wang, Hyo Jong Lee, Su Jin Jung, Yeon Ju Kim, Soo Bin Cho, Chae Hyeon Lee, Gyeongpyo Ham, Taegeun Oh, Sang Kook Lee, Yong Sup Lee. Scaffold hopping of N-benzyl-3,4,5-trimethoxyaniline: 5,6,7-Trimethoxyflavan derivatives as novel potential anticancer agents modulating hippo signaling pathway. European Journal of Medicinal Chemistry 2023; 256: 115421 doi: 10.1016/j.ejmech.2023.115421
|
26 |
Gautham Chengizkhan, Bharti Bisht, Sridhar Muthusami, Muralidharan Anbalagan, Ilangovan Ramachandran, R. Ileng Kumaran. Cancer Stem Cells: New Horizons in Cancer Therapies. 2020; : 15 doi: 10.1007/978-981-15-5120-8_2
|
27 |
Jungwhoi Lee, Jungsul Lee, Myungseung Kim, Jae Hoon Kim. Fermented Extraction ofCitrus unshiuPeel Inhibits Viability and Migration of Human Pancreatic Cancers. Journal of Medicinal Food 2018; 21(1): 5 doi: 10.1089/jmf.2017.3984
|
28 |
Hwa Jin Lee, Qian Wu, Hua Li, Gyu-Un Bae, An Keun Kim, Jae-Ha Ryu. A sesquiterpene lactone from Siegesbeckia glabrescens suppresses Hedgehog/Gli-mediated transcription in pancreatic cancer cells. Oncology Letters 2016; 12(4): 2912 doi: 10.3892/ol.2016.4994
|
29 |
Rishav Sharma, Rishabha Malviya. Cancer Stem Cells in Carcinogenesis and Potential Role in Pancreatic Cancer. Current Stem Cell Research & Therapy 2024; 19(9): 1185 doi: 10.2174/1574888X19666230914103420
|
30 |
E. Giovannetti, C.L. van der Borden, A.E. Frampton, A. Ali, O. Firuzi, G.J. Peters. Never let it go: Stopping key mechanisms underlying metastasis to fight pancreatic cancer. Seminars in Cancer Biology 2017; 44: 43 doi: 10.1016/j.semcancer.2017.04.006
|
31 |
Bhaskar Venkata Kameswara Subrahmanya Lakkakula, Batoul Farran, Saikrishna Lakkakula, Sujatha Peela, Nagendra Sastry Yarla, Pallaval Veera Bramhachari, Mohammad Amjad Kamal, Madhu Sudhana Saddala, Ganji Purnachandra Nagaraju. Small molecule tyrosine kinase inhibitors and pancreatic cancer—Trials and troubles. Seminars in Cancer Biology 2019; 56: 149 doi: 10.1016/j.semcancer.2018.09.011
|
32 |
Rebeca C.M. Dantas, Vanessa S.N. Guimarães, Renata O. de Souza, Ludmila F. Valverde, Manuela T.A. Vidal, Raphael L.R. Nogueira, Leonardo O.S. da Rocha, Giovana T. Araújo, Jean N. dos Santos, Clarissa A.G. Rocha. Immunodetection of Epithelial-Mesenchymal Transition and Tumor Proliferation Markers in GLi-1-positive Oral Squamous Cell Carcinoma. Applied Immunohistochemistry & Molecular Morphology 2021; 29(5): 335 doi: 10.1097/PAI.0000000000000866
|
33 |
Selvi Kunnimalaiyaan, Jose Trevino, Susan Tsai, T. Clark Gamblin, Muthusamy Kunnimalaiyaan. Xanthohumol-Mediated Suppression of Notch1 Signaling Is Associated with Antitumor Activity in Human Pancreatic Cancer Cells. Molecular Cancer Therapeutics 2015; 14(6): 1395 doi: 10.1158/1535-7163.MCT-14-0915
|
34 |
Madiha Niyaz, Mosin S. Khan, Rauf A. Wani, Omar J. Shah, Syed Mudassar. Sonic Hedgehog Protein is Frequently Up-Regulated in Pancreatic Cancer Compared to Colorectal Cancer. Pathology & Oncology Research 2020; 26(1): 551 doi: 10.1007/s12253-018-00564-2
|
35 |
Hwa Jin Lee, Ji Hye Jeong, Jae-Ha Ryu. Anti-pancreatic cancer activity of Z-ajoene from garlic: An inhibitor of the Hedgehog/Gli/FoxM1 axis. Journal of Functional Foods 2019; 56: 102 doi: 10.1016/j.jff.2019.03.010
|
36 |
Jungwhoi Lee, Jungsul Lee, Myungseung Kim, Jae Hoon Kim. Dietary approach to attenuate human pancreatic cancer growth and migration with innoxiousness. Journal of Functional Foods 2017; 30: 303 doi: 10.1016/j.jff.2016.12.032
|
37 |
Delphine Quatannens, Yannick Verhoeven, Peter Van Dam, Filip Lardon, Hans Prenen, Geert Roeyen, Marc Peeters, Evelien L.J. Smits, Jonas Van Audenaerde. Targeting hedgehog signaling in pancreatic ductal adenocarcinoma. Pharmacology & Therapeutics 2022; 236: 108107 doi: 10.1016/j.pharmthera.2022.108107
|
38 |
Jun Zhao, Zhilan Xiao, Tingting Li, Huiqin Chen, Ying Yuan, Y. Alan Wang, Cheng-Hui Hsiao, Diana S-L. Chow, Willem W. Overwijk, Chun Li. Stromal Modulation Reverses Primary Resistance to Immune Checkpoint Blockade in Pancreatic Cancer. ACS Nano 2018; 12(10): 9881 doi: 10.1021/acsnano.8b02481
|
39 |
Donger Zhou, Lei Zheng. Recent advances in cancer-associated fibroblast: Biomarkers, signaling pathways, and therapeutic opportunities. Chinese Medical Journal 2024; 137(6): 638 doi: 10.1097/CM9.0000000000003031
|
40 |
Sheng Chen, Min Zhang, Lili Xing, Yue Wang, Yongtao Xiao, Yeming Wu, Sharmila Shankar. HIF-1α Contributes to Proliferation and Invasiveness of Neuroblastoma Cells via SHH Signaling. PLOS ONE 2015; 10(3): e0121115 doi: 10.1371/journal.pone.0121115
|
41 |
Zhong-Yuan Hu, Ding Ding, Yu Song, Ya-Feng Deng, Cheng-Ming Zhang, Tao Yu. Molecular mechanism of pancreatic ductal adenocarcinoma: The heterogeneity of cancer-associated fibroblasts and key signaling pathways. World Journal of Clinical Oncology 2025; 16(2): 97007 doi: 10.5306/wjco.v16.i2.97007
|
42 |
Xin Liu, Jason R. Pitarresi, Maria C. Cuitiño, Raleigh D. Kladney, Sarah A. Woelke, Gina M. Sizemore, Sunayana G. Nayak, Onur Egriboz, Patrick G. Schweickert, Lianbo Yu, Stefan Trela, Daniel J. Schilling, Shannon K. Halloran, Maokun Li, Shourik Dutta, Soledad A. Fernandez, Thomas J. Rosol, Gregory B. Lesinski, Reena Shakya, Thomas Ludwig, Stephen F. Konieczny, Gustavo Leone, Jinghai Wu, Michael C. Ostrowski. Genetic ablation of Smoothened in pancreatic fibroblasts increases acinar–ductal metaplasia. Genes & Development 2016; 30(17): 1943 doi: 10.1101/gad.283499.116
|
43 |
Hideya Onishi, Katsuya Nakamura, Kosuke Yanai, Shuntaro Nagai, Kazunori Nakayama, Yasuhiro Oyama, Akiko Fujimura, Keigo Ozono, Akio Yamasaki. Cancer therapy that targets the Hedgehog signaling pathway considering the cancer microenvironment (Review). Oncology Reports 2022; 47(5) doi: 10.3892/or.2022.8304
|
44 |
Wanting Hou, Biao Yang, Hong Zhu. Nanoparticle-Based Therapeutic Strategies for Enhanced Pancreatic Ductal Adenocarcinoma Immunotherapy. Pharmaceutics 2022; 14(10): 2033 doi: 10.3390/pharmaceutics14102033
|
45 |
Sashikanta Swain, Ravi Kant Narayan, Pravash Ranjan Mishra. Unraveling the interplay: exploring signaling pathways in pancreatic cancer in the context of pancreatic embryogenesis. Frontiers in Cell and Developmental Biology 2024; 12 doi: 10.3389/fcell.2024.1461278
|
46 |
Do Luong Huynh, Hyebin Koh, Nisansala Chandimali, Jiao Jiao Zhang, Nameun Kim, Tae Yoon Kang, Mrinmoy Ghosh, Meeta Gera, Yang-Ho Park, Taeho Kwon, Dong Kee Jeong. BRM270 Inhibits the Proliferation of CD44 Positive Pancreatic Ductal Adenocarcinoma Cells via Downregulation of Sonic Hedgehog Signaling. Evidence-Based Complementary and Alternative Medicine 2019; 2019: 1 doi: 10.1155/2019/8620469
|
47 |
Kanar Hamaamin, Falah Hussein, Dena Mohammad. Immunohistochemical Expression of PTCH1 and Laminin in Oral Hyperplastic, Premalignant, Squamous Cell Carcinoma and Recurrence Lesions Samples. Sulaimani Dental Journal 2019; 6(1): 12 doi: 10.17656/sdj.10084
|
48 |
Pavan P. Adiseshaiah, Rachael M. Crist, Sara S. Hook, Scott E. McNeil. Nanomedicine strategies to overcome the pathophysiological barriers of pancreatic cancer. Nature Reviews Clinical Oncology 2016; 13(12): 750 doi: 10.1038/nrclinonc.2016.119
|
49 |
Jungwhoi Lee, Da-Hye Kim, Jae Hoon Kim. Combined administration of naringenin and hesperetin with optimal ratio maximizes the anti-cancer effect in human pancreatic cancer via down regulation of FAK and p38 signaling pathway. Phytomedicine 2019; 58: 152762 doi: 10.1016/j.phymed.2018.11.022
|
50 |
Zhengwei Xu, Chen Huang, Dingjun Hao. MicroRNA-1271 inhibits proliferation and promotes apoptosis of multiple myeloma cells through inhibiting smoothened-mediated Hedgehog signaling pathway. Oncology Reports 2017; 37(2): 1261 doi: 10.3892/or.2016.5304
|
51 |
Hui-Ching Wang, Wen-Chun Hung, Li-Tzong Chen, Mei-Ren Pan. From Friend to Enemy: Dissecting the Functional Alteration of Immunoregulatory Components during Pancreatic Tumorigenesis. International Journal of Molecular Sciences 2018; 19(11): 3584 doi: 10.3390/ijms19113584
|
52 |
Sharavan Ramachandran, Sanjay K. Srivastava. Repurposing Pimavanserin, an Anti-Parkinson Drug for Pancreatic Cancer Therapy. Molecular Therapy - Oncolytics 2020; 19: 19 doi: 10.1016/j.omto.2020.08.019
|
53 |
Shwetapadma Dash, Sonali Sahoo, Sanjeeb Kumar Sahoo. Recent Advances in Nanocarriers for Pancreatic Cancer Therapy. 2024; : 37 doi: 10.1016/B978-0-443-19142-8.00017-6
|
54 |
Naz Chaudary, Melania Pintilie, David Hedley, Richard P Hill, Michael Milosevic, Helen Mackay. Hedgehog inhibition enhances efficacy of radiation and cisplatin in orthotopic cervical cancer xenografts. British Journal of Cancer 2017; 116(1): 50 doi: 10.1038/bjc.2016.383
|
55 |
Libin Song, Xiangyuan Chen, Song Gao, Chenyue Zhang, Chao Qu, Peng Wang, Luming Liu. Ski modulate the characteristics of pancreatic cancer stem cells via regulating sonic hedgehog signaling pathway. Tumor Biology 2016; 37(12): 16115 doi: 10.1007/s13277-016-5461-8
|
56 |
Ying-Jie Li, Zhi-Long Wu, Qiang-Shuai Gu, Tingting Fan, Ming-Hao Duan, Lihong Wu, Yu-Tao Wang, Ji-Peng Wu, Fang-Lei Fu, Fan Sang, Ai-Ting Peng, Yuyang Jiang, Xin-Yuan Liu, Jin-Shun Lin. Catalytic Intermolecular Asymmetric [2π + 2σ] Cycloadditions of Bicyclo[1.1.0]butanes: Practical Synthesis of Enantioenriched Highly Substituted Bicyclo[2.1.1]hexanes. Journal of the American Chemical Society 2024; 146(50): 34427 doi: 10.1021/jacs.4c10968
|
57 |
Hideya Onishi, Akio Yamasaki, Makoto Kawamoto, Akira Imaizumi, Mitsuo Katano. Hypoxia but not normoxia promotes Smoothened transcription through upregulation of RBPJ and Mastermind-like 3 in pancreatic cancer. Cancer Letters 2016; 371(2): 143 doi: 10.1016/j.canlet.2015.11.012
|
58 |
Chen Liang, Si Shi, Qingcai Meng, Dingkong Liang, Jie Hua, Yi Qin, Bo Zhang, Jin Xu, Quanxing Ni, Xianjun Yu. MiR‐29a, targeting caveolin 2 expression, is responsible for limitation of pancreatic cancer metastasis in patients with normal level of serum CA125. International Journal of Cancer 2018; 143(11): 2919 doi: 10.1002/ijc.31654
|
59 |
Catherine Cochrane, Anette Szczepny, D. Watkins, Jason Cain. Hedgehog Signaling in the Maintenance of Cancer Stem Cells. Cancers 2015; 7(3): 1554 doi: 10.3390/cancers7030851
|
60 |
Shunrong Ji, Yi Qin, Chen Liang, Run Huang, Si Shi, Jiang Liu, Kaizhou Jin, Dingkong Liang, Wenyan Xu, Bo Zhang, Liang Liu, Chen Liu, Jin Xu, Quanxing Ni, Paul J. Chiao, Min Li, Xianjun Yu. FBW7 (F-box and WD Repeat Domain-Containing 7) Negatively Regulates Glucose Metabolism by Targeting the c-Myc/TXNIP (Thioredoxin-Binding Protein) Axis in Pancreatic Cancer. Clinical Cancer Research 2016; 22(15): 3950 doi: 10.1158/1078-0432.CCR-15-2380
|
61 |
Jichun Gu, Hexige Saiyin, Deliang Fu, Ji Li. Stroma — A Double-Edged Sword in Pancreatic Cancer. Pancreas 2018; 47(4): 382 doi: 10.1097/MPA.0000000000001023
|
62 |
Ann Mary Joseph, Ahmad Al Aiyan, Basel Al-Ramadi, Shiv K. Singh, Uday Kishore. Innate and adaptive immune-directed tumour microenvironment in pancreatic ductal adenocarcinoma. Frontiers in Immunology 2024; 15 doi: 10.3389/fimmu.2024.1323198
|
63 |
Diego J. Jiménez, Aadil Javed, Teresa Rubio-Tomás, Ndioba Seye-Loum, Carles Barceló. Clinical and Preclinical Targeting of Oncogenic Pathways in PDAC: Targeted Therapeutic Approaches for the Deadliest Cancer. International Journal of Molecular Sciences 2024; 25(5): 2860 doi: 10.3390/ijms25052860
|
64 |
Han-xiang Zhan, Jian-wei Xu, Dong Wu, Tai-ping Zhang, San-yuan Hu. Pancreatic cancer stem cells: New insight into a stubborn disease. Cancer Letters 2015; 357(2): 429 doi: 10.1016/j.canlet.2014.12.004
|
65 |
Nicolas Carels, Lizânia Borges Spinassé, Tatiana Martins Tilli, Jack Adam Tuszynski. Toward precision medicine of breast cancer. Theoretical Biology and Medical Modelling 2016; 13(1) doi: 10.1186/s12976-016-0035-4
|
66 |
Jerry Vriend, Saeid Ghavami, Hassan Marzban. The role of the ubiquitin proteasome system in cerebellar development and medulloblastoma. Molecular Brain 2015; 8(1) doi: 10.1186/s13041-015-0155-5
|
67 |
Janaiah Kota, Julie Hancock, Jason Kwon, Murray Korc. Pancreatic cancer: Stroma and its current and emerging targeted therapies. Cancer Letters 2017; 391: 38 doi: 10.1016/j.canlet.2016.12.035
|